Results 111 to 120 of about 2,326 (226)
Enhancer eccANKRD28‐manipulated MM cells have been demonstrated to facilitate drug resistance and promote MM progression by activating the key transcription factor, POU2F2. POU2F2 interacts with sequence‐specific eccANKRD28 as well as RUNX1 and RUNX2 motifs to form the protein complex, which activates the promoter of oncogenes (IRF4, JUNB, IKZF3, et al.
Binzhen Chen +12 more
wiley +1 more source
Principles of ecDNA random inheritance drive rapid genome change and therapy resistance in human cancers [PDF]
Joshua T. Lange +18 more
openalex +1 more source
Extrachromosomal Circular DNA in Cancer: Mechanisms and Clinical Applications
ABSTRACT Extrachromosomal circular DNA (eccDNA) has emerged as a critical area of cancer research due to its ubiquitous presence in tumour cells and significant role in tumorigenesis, progression and drug resistance. Recent studies demonstrate that eccDNA promotes cancer progression by influencing genomic instability, amplifying oncogenes, regulating ...
Jiajia Li +7 more
wiley +1 more source
IntroductionTraditional drug discovery efforts primarily target rapid, reversible protein-mediated adaptations to counteract cancer cell resistance. However, cancer cells also utilize DNA-based strategies, often perceived as slow, irreversible changes ...
Kohen Goble +18 more
doaj +1 more source
Becoming a selfish clan : recombination associated to reverse - transcription in LTR retrotransposons [PDF]
Drost, Hajk Georg. University of Cambridge. The Sainsbury Laboratory. United Kingdom.Sánchez, Diego H. Universidad de Buenos Aires. Facultad de Agronomía. Instituto de Investigaciones Fisiológicas y Ecológicas Vinculadas a la Agricultura (IFEVA).
Drost, Hajk Georg, Sánchez, Diego H.
core +2 more sources
Cancer: From a Genetic Disorder to a Systemic Disease
Advanced Science, Volume 12, Issue 42, November 13, 2025.
Ada Hang‐Heng Wong, Yuming Hu
wiley +1 more source
Environmental Drivers of Malignant Clonal Selection in Precancerous Lesion Evolution
ABSTRACT Somatic mutations accumulation and subsequent malignant clonal selection are the processes that lead to cancer. The intricacy includes exposure to carcinogens as well as the ways in which these exposures interact with genetic, polygenic, or epigenetic predispositions.
Yancheng Lai, Shaosen Zhang
wiley +1 more source
Summary: Neuroblastoma exhibits significant inter- and intra-tumor genetic heterogeneity and varying clinical outcomes. Extrachromosomal DNAs (ecDNAs) may drive this heterogeneity by independently segregating during cell division, leading to rapid ...
Maja C. Stöber +11 more
doaj +1 more source
CoRAL accurately resolves extrachromosomal DNA genome structures with long-read sequencing. [PDF]
Extrachromosomal DNA (ecDNA) is a central mechanism for focal oncogene amplification in cancer, occurring in ∼15% of early-stage cancers and ∼30% of late-stage cancers.
Bafna, Vineet +10 more
core +1 more source
Summary: The non-Mendelian inheritance of extrachromosomal DNA (ecDNA) exacerbates tumor genomic heterogeneity and evolution. Due to short-read sequencing’s reconstruction deficiencies, ecDNA abundance in clinical tumor tissues requires further ...
Ruoming Sun +10 more
doaj +1 more source

